Company: SRPT
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0000950170-25-064412
Chunk: 5

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-05-06
Form: 10-Q
Item: Part I, Item 1
Chunk 5
---
SAREPTA THERAPEUTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited, in thousands, except share and per share amounts)

     As of March 31, 2025

     As of December 31, 2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     240,867

     $
     1,103,010

     Short-term investments

     281,895

     251,782

     Accounts receivable, net

     659,371

     601,988

     Inventory

     941,432

     749,960

     Manufacturing-related deposits and prepaids

     203,490

     276,262

     Other current assets

     105,478

     90,461

     Total current assets

     2,432,533

     3,073,463

     Property and equipment, net

     360,587

     340,336

     Right of use assets

     147,063

     148,310

     Non-current inventory

     181,158

     187,986

     Strategic investments

     154,370

     3,710

     Non-current investments

     109,125

     133,163

     Other non-current assets

     80,551

     76,205

     Total assets
      
     $
     3,465,387

     $
     3,963,173

     Liabilities and Stockholders’ Equity

     Current liabilities:

     Accounts payable
      
     $
     156,105

     $
     214,442

     Accrued expenses

     391,650

     373,513

     Deferred revenue, current portion

     44,859

     130,256

     Other current liabilities

     12,974

     13,473

     Total current liabilities

     605,588

     731,684

     Long-term debt

     1,138,289

     1,137,124

     Lease liabilities, net of current portion

     205,460

     192,473

     Deferred revenue, net of current portion

     325,000

     325,000

     Contingent consideration

     47,